NCT00976508 2013-12-13Figitumumab Combined With Pegvisomant For Advanced Solid TumorsPfizerPhase 1 Terminated24 enrolled 10 charts
NCT00313781 2013-04-11Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC)PfizerPhase 2 Completed204 enrolled 12 charts